BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

466 hedge funds and large institutions have $14.7B invested in BioMarin Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 181 increasing their positions, 133 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
466
Holders Change
+31
Holders Change %
+7.13%
% of All Funds
9.2%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.2%
New
81
Increased
181
Reduced
133
Closed
45
Calls
$156M
Puts
$147M
Net Calls
+$8.14M
Net Calls Change
+$38.8M

Top Buyers

1
Dodge & Cox
Dodge & Cox
California
$371M
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$156M
3
Primecap Management
Primecap Management
California
$1.38B
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
$43.8M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
$52.8M

Top Sellers

1
Sands Capital Management
Sands Capital Management
Virginia
$0
2
Invesco
Invesco
Georgia
$52.4M
3
PHS
PFM Health Sciences
California
$46.8M
4
Viking Global Investors
Viking Global Investors
Connecticut
$137M
5
Jennison Associates
Jennison Associates
New York
$595M
Name Holding Trade Value Shares
Change 		Shares
Change %
UIM
26
USS Investment Management
United Kingdom
$99.6M +$37.5M +443,462 +60%
Northern Trust
27
Northern Trust
Illinois
$96.3M -$4.51M -53,379 -4%
FCM
28
Frontier Capital Management
Massachusetts
$93.6M +$30M +354,659 +47%
MNG
29
Manning & Napier Group
New York
$93M +$31.3M +370,098 +51%
Legal & General Group
30
Legal & General Group
United Kingdom
$84.3M +$3.47M +41,031 +4%
VOYA Investment Management
31
VOYA Investment Management
Georgia
$80.8M +$13.5M +159,125 +20%
First Trust Advisors
32
First Trust Advisors
Illinois
$73.2M +$750K +8,866 +1%
Nuveen Asset Management
33
Nuveen Asset Management
Illinois
$72.6M -$35.6M -421,396 -33%
PAMU
34
Pictet Asset Management (UK)
United Kingdom
$64.2M +$14.5M +171,567 +29%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$62.8M -$1.16M -13,716 -2%
TG
36
TCW Group
California
$62.6M -$2.71M -32,064 -4%
Loomis, Sayles & Company
37
Loomis, Sayles & Company
Massachusetts
$59M -$11.1M -131,710 -16%
Sumitomo Mitsui Trust Group
38
Sumitomo Mitsui Trust Group
Japan
$57.7M +$879K +10,398 +2%
SC
39
Samlyn Capital
New York
$57.1M +$15.1M +178,320 +36%
Fidelity Investments
40
Fidelity Investments
Massachusetts
$53.7M +$3.58M +42,371 +7%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$52.8M +$40.4M +477,401 +325%
Invesco
42
Invesco
Georgia
$52.4M -$138M -1,628,859 -72%
ZCI
43
Zevenbergen Capital Investments
Washington
$52M +$2.06M +24,370 +4%
Millennium Management
44
Millennium Management
New York
$51.6M +$30.2M +357,766 +142%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$50.4M +$12.3M +144,939 +32%
Franklin Resources
46
Franklin Resources
California
$49M -$55.2M -652,766 -53%
Charles Schwab
47
Charles Schwab
California
$48.7M +$7.11M +84,123 +17%
AAMU
48
Amundi Asset Management US
Massachusetts
$48.2M +$6.59M +77,914 +16%
Swiss National Bank
49
Swiss National Bank
Switzerland
$47.9M -$2.15M -25,400 -4%
PHS
50
PFM Health Sciences
California
$46.8M -$135M -1,595,417 -74%
1
2
3 4 5